Huang Jin-An, Wu Yu-Hsuan, Chen Po-Lin, Weng Yi-Chinn, Chiang I-Chen, Huang Yu-Ting, Chou Wen-Hai
Department of Neurology, Neurological Institute Taichung Veterans General Hospital, Taichung, Taiwan.
Department of Health Business Administration, Hungkuang University, Taichung, Taiwan.
Front Neurol. 2024 May 9;15:1400270. doi: 10.3389/fneur.2024.1400270. eCollection 2024.
Hemorrhagic transformation (HT) is a serious complication after endovascular thrombectomy (EVT) for patients with acute ischemic stroke (AIS). We analyzed the plasma levels of MMP-9 before and after EVT and assessed the temporal changes of MMP-9 that may be associated with, and therefore predict, HT after EVT.
We enrolled 30 AIS patients who received EVT, and 16 (53.3%) developed HT. The levels of MMP-9 in plasma collected from the arteries of AIS patients before and immediately after EVT were measured using ELISA. The percent change in MMP-9 after EVT (after/before) was calculated and compared between patients with and without HT.
The median age of the AIS patients was 70 years, and 13 patients (43.3%) were men. The median National Institutes of Health Stroke Scale (NIHSS) scores of patients with HT were 18 on admission and 18 after EVT. The median NIHSS scores of patients without HT were 17 on admission and 11 after EVT. Patients with HT demonstrated significantly greater percentage increases in arterial MMP-9 levels after EVT.
Patients with AIS who developed HT had significantly increased arterial MMP-9 levels after EVT, suggesting that the upregulation of MMP-9 following EVT could serve as a predictive biomarker for HT.
出血性转化(HT)是急性缺血性卒中(AIS)患者血管内血栓切除术(EVT)后的严重并发症。我们分析了EVT前后血浆基质金属蛋白酶-9(MMP-9)水平,并评估了MMP-9的时间变化,其可能与EVT后的HT相关,因此可用于预测HT。
我们纳入了30例接受EVT的AIS患者,其中16例(53.3%)发生了HT。使用酶联免疫吸附测定法(ELISA)测量AIS患者在EVT前及EVT后即刻从动脉采集的血浆中MMP-9的水平。计算EVT后MMP-9的变化百分比(术后/术前),并在发生和未发生HT的患者之间进行比较。
AIS患者的中位年龄为70岁,13例(43.3%)为男性。发生HT的患者入院时美国国立卫生研究院卒中量表(NIHSS)评分中位数为18分,EVT后为18分。未发生HT的患者入院时NIHSS评分中位数为17分,EVT后为11分。发生HT的患者在EVT后动脉MMP-9水平的百分比升高显著更大。
发生HT的AIS患者在EVT后动脉MMP-9水平显著升高,这表明EVT后MMP-9的上调可作为HT的预测生物标志物。